Spearhead Capital Advisors, LLC Athenex, Inc. Transaction History

Spearhead Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$0.79 - $1.59 $77,041 - $155,058	-97,521 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$1.36 - $2.94 $1,024 - $2,213	753 Added 0.78%	97,521 $133,000
Q3 2021 Oct 27, 2021	SELL	$2.97 - $4.84 $1,190 - $1,940	-401 Reduced 0.41%	96,768 $291,000
Q2 2021 Aug 10, 2021	BUY	$3.71 - $5.13 $200,202 - $276,830	53,963 Added 124.9%	97,169 $449,000
Q1 2021 Apr 28, 2021	BUY	$4.08 - $14.75 $176,280 - $637,288	43,206 New	43,206 $186,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.